TORONTO, ONTARIO--(Marketwire -09/06/12)- Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce that ...
AngioDynamics Inc. ( ANGO) recently won an expanded indication clearance from the FDA for its Celerity tip location system. Per the latest approval, clinicians can do away with the follow-up X-ray ...
Neonatal patients often require long-term vascular access for the delivery of life-sustaining medications and nutrition. The peripherally inserted central catheter (PICC) offers several advantages ...
From Jan 1, 2015, HealthTrust members will have access to AngioDynamics' entire PICC portfolio, including its thromboresistant BioFlo PICC product line and Celerity tip location system. The new ...
The use of peripherally inserted central venous catheters (PICC lines) has reduced the mortality and morbidity of premature newborns. The usual sites of insertion are the veins in the upper arms but ...
Several factors contraindicate PICC placement: lack of peripheral access, venous thrombosis, and end-stage renal disease. In addition, PICCs should not be used for frequent intermittent access or for ...
HARTWELL, Georgia. – A new study from PICC Excellence shows that standardizing ultrasound-guided PIV insertions in a hospital setting using an innovative sterile barrier dressing reduced costs by 73% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results